| Description | Maftivimab (REGN3470-3471-3479), also known as Atoltivimab, Odesivimab (Inmazeb), is a Filovirus inhibitor and a Food and Drug Administration (FDA)-approved agent for the research of Zaire ebolavirus infection [1]. |
| molecular weight | N/A |
| CAS | 2135632-36-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |